The HVTN 124 clinical trial testing WHV’s polyvalent DNA-prime/protein-boost vaccine opened for recruitment on March 16, 2018. The first volunteer was enrolled into the trial on April 19, 2018.
Learn more about our Vaccine Candidate
Learn more about the HVTN 124 trial
